Maureen F Loudovaris

Title: Maureen F Loudovaris: Innovator in Hematopoietic Cell Research

Introduction

Maureen F Loudovaris is a prominent inventor based in Grayslake, IL (US). She has made significant contributions to the field of hematopoietic cell research, holding a total of 3 patents. Her work focuses on developing serum-free, animal protein-free media formulations that enhance the growth of human hematopoietic cells.

Latest Patents

Loudovaris's latest patents include innovative methods for preparing serum-free suspensions of human hematopoietic cells. These formulations are designed to be used in conjunction with hematopoietic growth factors for the in vitro growth of human neutrophil and megakaryocyte precursors. The media contain a base medium, corticosteroid, transferrin, insulin, cholesterol, ethanolamine, and human albumin. Additionally, her patents provide methods for preparing suspensions that contain a significant percentage of neutrophil and megakaryocyte precursors, which are crucial for various medical applications.

Career Highlights

Loudovaris is currently associated with Nexell Therapeutics Inc., where she continues to advance her research in hematopoietic cell therapies. Her work is particularly relevant for patients undergoing myeloablative cancer treatments, as she has developed methods to infuse neutrophil precursors to combat neutropenia. This innovation helps to reduce the time patients spend in a neutropenic state, thereby improving their recovery and overall health outcomes.

Collaborations

Throughout her career, Loudovaris has collaborated with notable colleagues, including Stephen L Smith and Xiaoying Qiao. These partnerships have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Maureen F Loudovaris is a trailblazer in the field of hematopoietic cell research, with a focus on innovative solutions for patient care. Her contributions through her patents and work at Nexell Therapeutics Inc. highlight her commitment to advancing medical science and improving patient outcomes.